Unregistered cosmetics, packaging for suspected falsified antibiotics and branded bottle caps point to a deeper enforcement challenge: tracing who supplies, manufactures and distributes questionable products after the warehouses are discovered.
LAGOS, Nigeria — The most troubling aspect of the latest enforcement operation by Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) may not be the cosmetics discovered inside a building at Lagos Trade Fair Complex. It is what the packaging materials found alongside them could reveal about the infrastructure supporting the circulation of unregulated consumer products.
Behind the labels, empty containers, tubes and bottles are questions about the people who supply them, the facilities where products are manufactured, the distribution channels through which they reach consumers and the businesses that profit from a trade capable of exposing millions of Nigerians to potentially unsafe products.
On Saturday, November 14, 2026, NAFDAC announced that its enforcement officers had uncovered unlabelled and unregistered cosmetics and packaging materials at the Tools and Hardware Complex within the sprawling Trade Fair market in Ojo, Lagos State.
“An enforcement operation has uncovered unlabelled and unregistered cosmetics and packaging materials at the Tools and Hardware Complex, Trade Fair Complex, Lagos,” the agency stated in a post on its official X account, accompanied by footage of the operation.
The inspection, led by NAFDAC enforcement team leader Olakunle Ojo, revealed cosmetic packaging materials, empty shampoo tubes, lotion containers and other materials bearing descriptions associated with beauty products.
Officials also found already-produced cream and additional packaging materials spread across different floors of a two-storey building.
While examining the discoveries, Ojo remarked: “This is exactly what we are able to find at this particular location.”
The significance of the operation extended beyond cosmetics.
In a related discovery at the complex, NAFDAC identified a separate warehouse containing packaging materials for suspected falsified medicines, including Augmentin 625mg and Amplicloxa. Bottle caps bearing the Gordon’s Gin brand were also reportedly recovered.
According to TheCable, NAFDAC said the materials were not from the original manufacturers and that the Augmentin packaging differed from the packaging used by GlaxoSmithKline (GSK).
The distinction is important. The discovery of packaging materials bearing pharmaceutical or beverage brand names raises serious concerns about possible counterfeiting, but does not, by itself, establish that finished counterfeit medicines or alcoholic drinks were manufactured at those particular premises or subsequently sold.
The agency has not publicly provided a complete inventory, estimated value of the latest discoveries, the identities of the premises’ operators or details of any arrests arising from the November 14 operation.
The packaging industry behind counterfeit medicines
Counterfeit products do not necessarily begin with the manufacture of the substance inside a bottle, tube or packet. Their credibility can depend on how convincingly they imitate the packaging, branding and identification features of legitimate products.
This is particularly concerning in the pharmaceutical industry, where patients and healthcare providers depend on accurate product information to establish a medicine’s identity, manufacturer, dosage, batch and expiry date.
Packaging bearing the name of an established antibiotic can potentially be used to make an unauthorised product appear legitimate. A convincing label, carton, leaflet or container can mislead consumers who have little ability to independently establish the medicine’s contents.
The discovery is especially sensitive because Augmentin has already featured in a separate counterfeit medicine alert issued by NAFDAC this year.
On April 30, 2026, the agency issued Public Alert No. 024/2026 warning Nigerians about counterfeit Augmentin 625mg tablets bearing batch number AC3N.
The alert followed complaints received by GSK, the genuine manufacturer’s marketing authorisation holder in Nigeria.
NAFDAC reported that GSK confirmed the suspected tablets were counterfeit after examining documentary evidence, photographs and a social media video.
The agency explained that although the counterfeit tablets carried a batch number associated with genuine stock, the manufacturing and expiry dates were inconsistent with the manufacturer’s production records.
The genuine batch had been manufactured in the United Kingdom on August 23, 2023, and packed between September 19 and 20, 2023. The counterfeit samples reportedly carried manufacturing and expiry dates of September 2025 and September 2028.
NAFDAC warned that counterfeit Augmentin could contain incorrect quantities of active ingredients, no active ingredient or potentially harmful substances.
The consequences could include treatment failure, worsening bacterial infections, adverse reactions and antimicrobial resistance.
There is no publicly established evidence linking the packaging discovered at Trade Fair in November to the counterfeit Augmentin batch identified in April. Nevertheless, the recurrence of the same pharmaceutical brand in two separate counterfeit-related developments makes the latest discovery particularly important for investigators.
The World Health Organisation has repeatedly highlighted the global dimensions of the problem.
Its December 2024 fact sheet estimates that at least one in 10 medicines in low- and middle-income countries is substandard or falsified. This is a global estimate, not a Nigeria-specific measurement.
The WHO warns that falsified products can contain incorrect ingredients, incorrect dosages or harmful substances, potentially undermining treatment and endangering patients.
For a country where access to affordable and reliable healthcare remains a major concern, the possibility of counterfeit antibiotics entering legitimate distribution channels deserves sustained regulatory attention.
Why unregistered cosmetics are a public-health concern
Cosmetics are sometimes treated as relatively low-risk consumer goods compared with medicines. That assumption can be misleading.
Skin-lightening creams, moisturisers, soaps, shampoos and other personal-care products are applied directly to the body, sometimes repeatedly over extended periods.
Their safety depends on the ingredients, manufacturing conditions, product stability, storage and accurate information supplied to consumers.
An unregistered product is not automatically poisonous or harmful. But without proper regulatory assessment, consumers have less assurance about its composition, quality, manufacturing origin and safety.
This is why Nigeria’s cosmetics registration requirements are more than bureaucratic procedures.
NAFDAC’s guidelines explicitly state that cosmetics must be registered before they can be manufactured, imported, exported, advertised, sold, distributed or used in Nigeria.
The agency’s Cosmetics Products Labelling Regulations also establish requirements for the information that must appear on products.
These include:
- Brand name and product identity.
- A complete list of ingredients.
- Lot or batch number.
- Net content.
- Expiry date.
- Manufacturer’s name and country of origin.
- NAFDAC registration number.
- Appropriate storage conditions.
Labels must also be informative, accurate, prominent and legible. Product claims must be substantiated, and information must not mislead consumers about the product’s character, quality or origin.
These requirements provide the foundation for tracing products, identifying manufacturers, investigating complaints and initiating recalls when safety problems emerge.
Without reliable labelling, consumers may be unable to establish what they are applying to their skin or identify the business responsible when something goes wrong.
The discovery of cosmetics packaging and already-produced cream at Trade Fair should therefore prompt NAFDAC to establish the composition of the substances recovered, the identities of their manufacturers and whether any of the products had entered commercial distribution.
That investigation should establish actual risks through laboratory analysis rather than assume that every unidentified product is necessarily toxic.
A market repeatedly appearing in NAFDAC investigations
The latest operation did not occur in isolation.
The Trade Fair Complex has featured prominently in several NAFDAC enforcement operations involving suspected counterfeit, banned and unregistered products.
In February 2026, the agency uncovered a warehouse containing banned, fake and unregistered cosmetics valued at more than ₦3 billion at the APT Trade Fair Complex.
The facility was reportedly concealed inside an unfinished building.
Among the products recovered were 728 cartons of Crusader soap, 718 cartons of E45 soap and quantities of Extract Gold whitening soap. NAFDAC identified these products as prohibited.
Assorted perfumes, body oils and cooking oils were also discovered and placed on hold for further regulatory assessment.
The agency said the products had been evacuated to prevent their distribution and that the warehouse manager had been invited for investigation.
Another major operation took place in October.
NAFDAC uncovered more than 20 illegal stores at the International Trade Fair Complex, where products valued at over ₦2 billion were seized.
Two suspects were arrested over alleged involvement in counterfeit alcoholic beverage operations, the revalidation of expired or unsafe drinks and the stockpiling of banned imported products.
According to reports, the operation exposed activities involving the removal or alteration of expiry labels, the use of packaging materials and the suspected reprocessing of beverages for resale.
The agency also reported alleged arrangements through which revalidated drinks were supplied to bars and nightclubs.
These October discoveries and the November cosmetics operation occurred in different parts of the sprawling commercial complex. There is no established evidence that they involved the same individuals or business network.
Nevertheless, their recurrence raises an important regulatory question: how many separate operations will be required before the supply infrastructure supporting illegal manufacturing, repackaging and distribution is comprehensively mapped?
Trade Fair is a major commercial centre serving legitimate businesses and consumers. The activities of suspected illegal operators should not be used to criminalise the wider trading community.
The challenge is to identify and isolate unlawful operations without unnecessarily disrupting legitimate commerce.
Kano reveals that the problem extends beyond cosmetics
The developments in Lagos also coincide with another significant NAFDAC enforcement operation in northern Nigeria.
In Kano State, the agency sealed four warehouses and seized prohibited chemicals valued at approximately ₦560 million during an operation targeting the alleged storage, distribution and sale of banned substances.
Two people were arrested, including the owner of one of the warehouses.
Mr Emmanuel Andrew, Deputy Director of Investigation and Enforcement at NAFDAC, disclosed that the operation targeted Paraeforce, commonly known as Paraquat.
The agency had banned the importation of Paraquat in 2022 and scheduled enforcement of the prohibition to begin on January 1, 2024.
NAFDAC’s subsequent regulatory directive, effective May 20, 2025, expressly prohibits its manufacture, importation, exportation, distribution, advertisement, sale and use as a herbicide.
The agency identifies Paraquat as highly toxic to humans and the environment, warning that exposure can cause acute respiratory distress and other serious complications.
In Kano, investigators reportedly recovered 2,983 cartons of Paraeforce products valued at more than ₦200 million and more than 8,000 cartons of Crownquat, a Paraquat-based product, valued at over ₦360 million.
NAFDAC also reported discovering facilities suspected of unauthorised chemical manufacturing and repackaging.
Although the Kano operation concerns prohibited agricultural chemicals rather than cosmetics or counterfeit medicines, it highlights a common regulatory problem: the persistence of prohibited or unauthorised products within commercial supply networks despite existing restrictions.
The question is no longer simply whether Nigeria has regulations prohibiting dangerous products. It is whether regulatory institutions can consistently prevent those products from being manufactured, stored, repackaged and distributed.
The unanswered questions behind the Lagos discoveries
For NAFDAC, the November 14 operation should be the beginning of a wider investigation rather than an isolated enforcement success.
Several issues require answers.
First, who owns and operates the premises?
Investigators need to establish the identities of the tenants, warehouse operators, business owners and individuals responsible for the recovered materials.
Second, where did the packaging materials originate?
The authorities should establish whether the materials were produced locally or imported, who commissioned their production and whether the suppliers maintained records of the businesses purchasing them.
Third, were the materials intended for actual production?
Laboratory investigations and examination of production equipment could establish whether cosmetics had already been manufactured, whether the products met regulatory standards and whether the materials were connected to suspected falsified medicines.
Fourth, where were the finished products going?
This is perhaps the most important question.
Investigators should trace any established distribution networks, identify wholesalers and retailers where evidence supports it, and determine whether products had entered pharmacies, beauty shops, open markets, supermarkets or online marketplaces.
Finally, what happens after the raids?
Seizures and warehouse closures are important, but their long-term value depends on prosecution, appropriate sanctions, the recovery of evidence and the dismantling of unlawful supply arrangements.
NAFDAC should provide periodic public updates detailing confirmed findings, prosecutions, laboratory results and the outcomes of investigations.
Without such information, the public may see repeated enforcement announcements without being able to determine whether the underlying networks have actually been dismantled.
The agency’s own laws provide the statutory foundation for its responsibilities. The NAFDAC Act establishes its regulatory mandate, while the legislation governing counterfeit and fake drugs prohibits the sale and distribution of counterfeit, adulterated, banned, substandard or expired medicines.
What Nigerian consumers should do
The responsibility for product safety cannot rest exclusively on regulators. Consumers, retailers, distributors and healthcare professionals also have important roles.
Nigerians purchasing cosmetics should pay attention to product labels, ingredient information, manufacturer details, batch numbers, expiry dates and NAFDAC registration information.
The agency operates its NAFDAC Automated Product Administration and Monitoring System (NAPAMS), which allows consumers to verify products using their NAFDAC registration numbers.
However, the presence of a printed registration number should not automatically be regarded as conclusive proof of authenticity. Suspected products should be checked through NAFDAC’s official verification channels.
Medicines should be purchased from authorised pharmacies and licensed suppliers rather than informal sources where product history and storage conditions cannot be established.
NAFDAC also launched an improved Med Safety App in June 2026 to enable healthcare professionals and members of the public to report suspected substandard and falsified medical products and adverse drug reactions.
For complaints and enquiries, the agency publishes the following telephone contacts:
- Complaints: 0800-1-NAFDAC (0800-1-623322).
- Enquiries: 0700-1-NAFDAC (0700-1-623322).
Consumers should report suspicious products rather than attempt to establish their chemical composition or safety through personal experimentation.
Beyond the warehouse, Nigeria must dismantle the network
NAFDAC’s latest discovery at Lagos Trade Fair exposes an uncomfortable reality about consumer protection in Nigeria.
Dangerous or unauthorised products do not reach consumers by accident. Where deliberate counterfeiting or illegal manufacturing is established, the activity depends on suppliers, materials, production facilities, storage arrangements, distribution channels and willing buyers.
The recovery of cosmetic packaging, suspected falsified medicine materials and branded beverage caps makes the need for a deeper investigation particularly urgent.
The agency deserves credit for acting on intelligence and identifying facilities requiring investigation. But enforcement effectiveness should ultimately be measured by more than warehouses discovered, products recovered or videos published.
The decisive test is whether investigators can identify the people financing these operations, trace their supply chains, establish where their products went and secure successful legal outcomes against those responsible.
Until that happens, the next raid may reveal another warehouse containing a different collection of labels, bottles, creams or packaging materials.
And Nigerian consumers will remain exposed to a marketplace in which the appearance of a trusted brand may not always guarantee the authenticity of what is inside the package.
Follow us on our broadcast channels today!
- WhatsApp: https://whatsapp.com/channel/0029VawZ8TbDDmFT1a1Syg46
- Telegram: https://t.me/atlanticpostchannel
- Facebook: https://www.messenger.com/channel/atlanticpostng
Join the debate; let’s know your opinion.